Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biological characteristics of pancreatic ductal adenocarcinoma: Initiation to malignancy, intracellular to extracellular
Ou Li, Li Li, Yunru Sheng, et al.
Cancer Letters (2023) Vol. 574, pp. 216391-216391
Open Access | Times Cited: 20

Showing 20 citing articles:

Evaluation of a new scoring system for assessing nerve invasion in resected pancreatic cancer: a single-center retrospective analysis
Rong Hua, Hong-Fei Yao, Zi-Yu Song, et al.
Cancer Letters (2024) Vol. 603, pp. 217213-217213
Closed Access | Times Cited: 7
Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer
Xing Wang, Xiaohong Liu, Ruiling Xiao, et al.
Cancer Letters (2024) Vol. 598, pp. 217117-217117
Open Access | Times Cited: 6
Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Rahat Jahan, Sophia G. Kisling, et al.
Cancer Letters (2024) Vol. 598, pp. 217097-217097
Closed Access | Times Cited: 4
Unveiling SMAD family member 6 as a novel biomarker for prognosis and immunotherapy response in testicular germ cell tumors
Huan Lin, Xiaowen Lin, Peisheng Huang, et al.
Andrology (2025)
Open Access
Cell-free DNA: plays an essential role in early diagnosis and immunotherapy of pancreatic cancer
Yi Wen, Grace Zhao, Chunhua Dai
Frontiers in Immunology (2025) Vol. 16
Open Access
Pancreatic Cancer: Pathogenesis and Clinical Studies
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Gap-App: A Sex-Distinct AI-Based Predictor for Pancreatic Ductal Adenocarcinoma Survival as A Web Application Open to Patients and Physicians
Anuj Ojha, Shujun Zhao, Basil Akpunonu, et al.
Cancer Letters (2025), pp. 217689-217689
Open Access
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Vasiliki Liaki, Blanca Rosas-Pérez, Carmen Guerra
Cancers (2025) Vol. 17, Iss. 7, pp. 1226-1226
Open Access
Integrated analysis of scRNA-seq and bulk RNA-seq data identifies BHLHE40 as a key gene in pancreatic cancer progression and gemcitabine resistance
Yang Wu, Chun Zhang, Jiayi Huang, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 2, pp. 152338-152338
Closed Access
Cascade Ultrasonic Cavitation Enables Microbubble–Nanoparticle Hybrid to Broadly Accumulate and Penetrate into Pancreatic Ductal Adenocarcinoma
Dequan Ye, Guowei Wang, Xiao Liu, et al.
Small Structures (2025)
Open Access
IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone
Richard E. Kast
Oncoscience (2024) Vol. 11, pp. 15-31
Open Access | Times Cited: 3
Unraveling Pancreatic Ductal Adenocarcinoma Immune Prognostic Signature through a Naive B Cell Gene Set
Shichen Zhang, Na Ta, Shihao Zhang, et al.
Cancer Letters (2024) Vol. 594, pp. 216981-216981
Closed Access | Times Cited: 3
Driver mutation subtypes involve with differentiated immunophenotypes influencing pancreatic cancer outcomes
Siyi Zou, Lei Zhang, Cen Jiang, et al.
Cancer Letters (2024) Vol. 599, pp. 217134-217134
Open Access | Times Cited: 3
Enhanced cytokine signaling and ferroptosis defense interplay initiates obesity-associated pancreatic ductal adenocarcinoma
Rexiati Ruze, Cheng Yuan, Jianlu Song, et al.
Cancer Letters (2024) Vol. 601, pp. 217162-217162
Closed Access | Times Cited: 3
Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis
Jianzhou Liu, Bolun Jiang, Wenchao Xu, et al.
Cancer Letters (2024) Vol. 605, pp. 217280-217280
Closed Access | Times Cited: 3
Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells
Aun Ali Bangash, Sahir Sultan Alvi, Muhammad Bangash, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3431-3431
Open Access | Times Cited: 1
Pirfenidone Antagonizes TGF-β1-Mediated Gabapentin Resistance via Reversal of Desmoplasia and the ‘Cold’ Microenvironment in Pancreatic Cancer
Jing Zhang, Junrong Zhang, Ronggui Lin, et al.
Cancer Letters (2024) Vol. 605, pp. 217287-217287
Open Access | Times Cited: 1
Peptidase inhibitor 16 promotes proliferation of pancreatic ductal adenocarcinoma cells through OASL signaling
Qun Chen, Lu‐Yang Jiang, Cheng Cao, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 5, pp. 938-950
Closed Access | Times Cited: 1
Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer
Xinlei Sun, Daowei Yang, Yang Chen
Cells (2023) Vol. 12, Iss. 22, pp. 2614-2614
Open Access | Times Cited: 1
DNA Repair Status as a Guide for Pancreatic Ductal Adenocarcinoma Treatment, an Old View for a New Future.
Robert C.A.M. van Waardenburg
Cancer Letters (2024) Vol. 604, pp. 217222-217222
Closed Access
Page 1

Scroll to top